Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: Case report and review

Endocrine Practice

Volumn 14, Issue 6, 2008, Pages 713-716

  Miller, Barbra S ^a   Rusinko, Rachel Y ^b   Fowler, Larry ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER SCREENING; CANCER STAGING; CARCINOID; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA; PROGNOSIS; THYMECTOMY; THYMOMA; THYMUS CANCER; MIDDLE AGED; PATHOLOGY; REVIEW;

CARCINOID TUMOR; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; THYMOMA; THYMUS NEOPLASMS;

EID: 64749103124     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.6.713     Document Type: Article

References (14)

1. Teh BT, Zedenius J, Kytölä S, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998;228:99-105.
2. Schmidt R, Mönig SP, Selzner M, Krug B. Surgical therapy of malignant thymoma. J Cardiovasc Surg (Torino). 1997;38:317-322.
3. Currans WJ Jr, Kornstein MJ, Brooks JT, Turrisi AT III. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete resection. J Clin Oncol. 1988;6:1722-1727.
4. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival [with discussion]. Ann Thorac Surg. 1995;60:908-914.
5. Loehrer PJ Sr, Kim K, Aisner SC, et al (Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group). Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol. 1994;12:1164-1168.
6. Shin DM, Walsh GL, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med. 1998;129:100-104.
7. Wick MR, Scott RE, Li CY, Carney JA. Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc. 1980;55:246-254.
8. Doherty GM. Multiple endocrine neoplasia type 1. J Surg Oncol. 2005;89:143-150.
9. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepherd JJ. Cause of death in multiple endocrine neoplasia type 1. Arch Surg. 1993;128:683-690.
10. Duh QY, Hybarger CP, Geist R, et al. Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg. 1987;154:142-148.
11. Sugiura H, Morikawa T, Itoh K, et al. Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: report of a case. Surg Today. 2001;31:428-432.
12. Gibril F, Chen YJ, Schrump DS, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88:1066-1081.
13. Lim LC, Tan MH, Eng C, Teh BT, Rajasoorya RC. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention. J Intern Med. 2006;259:428-432.
14. Burgess JR, Giles N, Shepherd JJ. Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2001;55:689-693.